Related Experiment Video
Updated: Nov 20, 2025

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
Published on: April 14, 2016
Multi-Modal Analgesic Strategy for Trauma: A Pragmatic Randomized Clinical Trial
John A Harvin1, Rondel Albarado2, Van Thi Thanh Truong3
1Center for Translational Injury Research, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX; Department of Surgery, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX; Center for Clinical Research and Evidence-Based Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX.
The Multi-Modal Analgesic Strategies for Trauma (MAST) regimen effectively reduced opioid exposure in injured patients compared to the original multimodal pain regimen (MMPR). This approach achieved adequate acute pain control while minimizing opioid use in a trauma center.
Area of Science:
- Trauma surgery
- Pain management
- Pharmacology
Background:
- Effective strategies are needed to manage acute pain and reduce opioid exposure in injured patients.
- Multimodal pain regimens (MMPRs) are a key approach in trauma care.
- Urban trauma centers face challenges in optimizing pain management protocols.
Purpose of the Study:
- To compare two MMPRs for their effectiveness in minimizing opioid exposure and relieving acute pain.
- To evaluate the impact of a generic medication-based MMPR on opioid use in trauma patients.
- To assess pain scores and opioid prescribing patterns in trauma admissions.
Main Methods:
- An unblinded, pragmatic, randomized comparative effectiveness trial was conducted.
- Adult trauma admissions were randomized to either the original MMPR or the Multi-Modal Analgesic Strategies for Trauma (MAST) MMPR.
- Primary endpoint was oral morphine milligram equivalents (MMEs) per day; secondary outcomes included total MMEs, discharge opioid prescriptions, and pain scores.
Main Results:
- The MAST MMPR resulted in significantly lower MMEs per day (34 vs. 48 MMEs/d; p < 0.001).
- Fewer patients receiving the MAST MMPR were prescribed opioids at discharge (62% vs. 67%; p = 0.029).
- No clinically significant differences in pain scores were observed between the two groups.
Conclusions:
- The MAST MMPR is a generalizable and accessible approach for reducing opioid exposure post-trauma.
- This generic medication-based regimen effectively controls acute pain in trauma patients.
- The findings support the adoption of the MAST MMPR in busy urban trauma centers.
Related Concept Videos
Analgesia and Pain Management
Opioid Analgesics: Synthetic and Semisynthetic Opioids

